Clinical Trial Update: Comparative Study of REMAXA®, Enteric-coated Tablets and REMAXOL®, Solution for Infusions, in Intrahepatic Cholestasis [Phase 2, Phase 3]

View source ↗

Summary

A phase 2/3 clinical trial evaluating REMAXA enteric-coated tablets and REMAXOL infusion for intrahepatic cholestasis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intrahepatic Cholestasis

Drugs mentioned

• REMAXA
• Remaxol

Snippet

Sponsor: POLYSAN Scientific & Technological Pharmaceutical Company | Conditions: Cholestasis, Intrahepatic | Phase 2, Phase 3 | Status: COMPLETED